Pemzek 4 mg
Pemzek 4 mg is a medicine authorised by Swissmedic under authorisation number 62498. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 January 2012 and the authorisation is valid without a time limit. ATC code C09CA06 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 62498 |
|---|---|
| Name | Pemzek 4 mg |
| Full name | Pemzek 4 mg, Tabletten |
| Authorisation holder | AstraZeneca AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09CA06 |
| First authorisation | 06 January 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pemzek 4 mg, Tabletten | B | 06 January 2012 |
| 2 | Pemzek 8 mg, Tabletten | B | 06 January 2012 |
| 3 | Pemzek 16 mg, Tabletten | B | 06 January 2012 |
| 4 | Pemzek 32 mg, Tabletten | B | 06 January 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 7 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 8 | 30 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 12 | 28 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 2 | 28 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 3 | 98 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 9 | 30 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 4 | 28 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 5 | 98 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 10 | 30 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 6 | 28 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 7 | 98 | Tablette(n) | C09CA06 | 02.07.1. | B |
| 11 | 30 | Tablette(n) | C09CA06 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pemzek 4 mg authorised in Switzerland?
Yes. Pemzek 4 mg is authorised by Swissmedic under authorisation number 62498, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pemzek 4 mg have?
Pemzek 4 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Pemzek 4 mg?
The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.